Market closed

United Therapeutics/$UTHR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About United Therapeutics

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Ticker

$UTHR
Trading on

Industry

Biotechnology

Employees

1,305

UTHR Metrics

BasicAdvanced
$14B
12.23
$25.10
0.63
-
$14B
0.63
$403.35
$260.41
450K
5.461
5.05
2.938
41.28%
12.97%
19.94%
12.226
4.58
2.03
2.07
12.149
19.85%
18.87%
19.19%
20.26%

What the Analysts think about UTHR

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for United Therapeutics stock.

UTHR Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

UTHR Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $UTHR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for United Therapeutics stock?

What is the P/E ratio for United Therapeutics stock?

Does United Therapeutics stock pay dividends?

When is the next United Therapeutics dividend payment date?

What is the beta indicator for United Therapeutics?